Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Prime Medicine (PRME) Leases (2021 - 2025)

Prime Medicine's Leases history spans 5 years, with the latest figure at $126.2 million for Q4 2025.

  • For Q4 2025, Leases rose 167.57% year-over-year to $126.2 million; the TTM value through Dec 2025 reached $126.2 million, up 167.57%, while the annual FY2025 figure was $126.2 million, 167.57% up from the prior year.
  • Leases reached $126.2 million in Q4 2025 per PRME's latest filing, up from $117.9 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $126.2 million in Q4 2025 to a low of $10.7 million in Q4 2021.
  • Average Leases over 5 years is $47.8 million, with a median of $29.5 million recorded in 2022.
  • Peak YoY movement for Leases: tumbled 57.7% in 2024, then surged 963.74% in 2025.
  • A 5-year view of Leases shows it stood at $10.7 million in 2021, then surged by 174.94% to $29.5 million in 2022, then tumbled by 52.81% to $13.9 million in 2023, then skyrocketed by 238.25% to $47.2 million in 2024, then skyrocketed by 167.57% to $126.2 million in 2025.
  • Per Business Quant, the three most recent readings for PRME's Leases are $126.2 million (Q4 2025), $117.9 million (Q3 2025), and $120.2 million (Q2 2025).